LUKAS BIOMEDICAL INC.

The exhibited product of Lukas Biomedical Inc. is Autologous Activated T Lymphocyte (ATL), as known as CIK (Cytokine Induce Killer Cells) which is T cell that has long life-span, high specificity, and regeneration ability to prolong its interaction duration in the immune system. It plays a crucial role in the anti- cancer mechanism. They are isolated from the peripheral blood of patients and generated as a cell cluster through co-culture with cytokine (such as IL-2 and CD3 antibody). This cell cluster includes several immune cells with different surface antigens. In early studies, it was found that the majority of these immune cells are CD4+ and CD8+ T lymphocytes. CD4+ helper T cells have the function of secreting cytokine to assist other immune cells, and CD8+ cytotoxic T cells have tumor-specific killing capacity. This tumor-specific killing capacity plays a critical role in the immune system to against cancer. In the latest year, CD3+CD56+ NKT cells, and CD3-CD56+ NK cells and other killer cells with cytotoxicity have also been discovered in the cell cluster.
The immunotherapy of Lukas has the following unique traits:
1. A One-time 80 ml blood collection from the patient can conduct total of six infusions. It avoids repeated blood collections from the patient.
2. Premium quality and quantity- the cell proliferation can be up to 1000 fold with 95% purity.
3. The results of phrase two and phrase three clinical trials showed that Lukas’ memory T immunotherapy could significantly prolong time to cancer recurrence.
4. This technology comes from Japan and has been on the market in South Korea. It has been manipulated on more than 10,000 patients and it has proved as safe and effective.

LuminX Biotech Co., Ltd

LuminX Biotech dedicates to accelerate the optimization of cell-therapy-products through specific understanding of therapeutic cells distribution in-vivo, long-term viability, as well as their biological fate either in preclinical or clinical setting and our technologies can transition a potential therapy from the research stage to advanced clinical and commercial applications to save lives.

LumiSTAR Biotechnology, Inc.

LumiSTAR Biotechnology focuses on development of various drug screening platforms for pharmaceutical and CRO companies. We have been committed to accelerate drug development process. Our core technologies are various optical genetically-encoded reporters (with different detection dynamic ranges), which can be incorporated with iPSC or disease-model cell lines for real-time monitoring how the cellular physiology influenced by testing drugs. LumiSTAR’s drug screening platform can apply on phenotypic screening, drug discovery, toxicity testing, and precision/personalized medicine.
LumiSTAR’s COVID-19 related products include a range of mutant strains of pseudovirus for cell based high throughput neutralizing screening, which can evaluate antibodies or drugs that inhibit virus entry. Our antigen detection and neutralizing antibody assays are special designed to simplify operating procedures. All the COVID-19 related products are commercialized and open for services. Testing kits of in vitro assays, which are compatible with most of ELISA readers, are also available for sale.

Ma-tek

Bio-TEM、Drug analysis、Liquid TEM、K-kit

Medicare Products Inc.

Multiplex Diagnostics tool by Seegene

MEDIGEN BIOTECHNOLOGY CORP.

New Era of Cell Therapy- Application of NK cell and Gamma-Delta T Cell in Cancer Therapy
Introduction of Covid-19 NAT and PCR equipment

METATECH(AP)INC.

待補

MiCareo Taiwan Co., Ltd.

Automated Microfluidic Sorting and Imaging System
Product Intro.:
1. ALL-IN-ONE and automation.
2. Accepts all liquid biopsies, such as whole blood, can be processed without using lysis or density centrifugation.
3. Even one single cell in 8 mL of whole blood can be found with greater than 97% sensitivity and 0% false positive rate.
4. The isolated individual cells are now automatically incubated with up to 13 different antibodies.
5. Preserving the integrity of the cells with 99% survival, affording access to the complete range of genomic and cell culture.

Micro Solutions Sp. j.

We’re an ISO 13485 certified medical IT company empowering clinical, diagnostic, and research laboratories to improve their TAT, and data management, so they can make more tests, improve diagnosis, get results faster, and do anything that in the end contributes to the health and well-being of patients.
We help laboratory device manufacturers connect with LIMS solutions over HL7, ASTM, POCT1-A, LIS2-A2, and other proprietary protocols. With our ISO 13485, we simplify and accelerate procedures related to the registration of medical devices. We extract valuable information from medical images (multispectral, X-ray, light and confocal microscopy) using advanced image processing and elements of machine learning and AI.

Miltenyi Biotec B.V. & Co. KG

Miltenyi Biotec commits to promoting the automation of the cell therapy industry, whether it is GMP-compliant raw materials or automation equipment, all provide innovative solutions for you.